Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects and safety of pioglitazone and berberine
on the basis of lifestyle intervention to non-alcoholic fatty liver disease patients with
impaired glucose regulation or type 2 diabetes mellitus.
Phase:
Phase 2
Details
Lead Sponsor:
Xin Gao
Collaborators:
Shanghai Jiao Tong University School of Medicine Shanghai Municipal Science and Technology Commission